Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:P20366 (substance P)
 21,176 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Using the indirect immunofluorescence technique of Coons and collaborates, somatostatin-like immunoreactivity was found in skin lesions of patients presented with urticaria pigmentosa. The cytoplasmic immunoreactivity was sometimes of a granular type. In addition, immunofluorescence was also observed in certain surrounding connective tissue elements. No specific staining was seen when supplementing the first antiserum with control serum, nor could any unique specific immunofluorescence by found in the pathological areas (compared with skin of normal healthy volunteers) after incubation with antibodies to substance P, vasoactive intestinal polypeptide or avian pancreatic polypeptide. No thyrotropin releasing hormone or enkephalin immunoreactivity was seen in skin from either the patients or the controls.
 ...
PMID:Immunohistochemical localization of somatostatin-like immunoreactivity in skin lesions from patients with urticaria pigmentosa. 620 41

Patients with urticaria pigmentosa were investigated during symptom-free interval regarding plasma concentrations and urinary excretion of immunoreactive regulatory peptides: calcitonin gene-related peptide (CGRP), gastrin, neurokinin A (NKA), neuropeptide Y (NPY), somatostatin (SOM), substance P (SP) and vasoactive intestinal peptide (VIP). The plasma concentrations of these peptides, except for CGRP, were below the detection limit. The urinary excretion of the regulatory peptides were not higher in the patient group than in the controls, but in individual patients there was high urinary excretion of SP and VIP. A lower urinary excretion of CGRP was found in the patient group in addition to a tendency to a lower plasma concentration.
 ...
PMID:Plasma concentrations and urinary excretion of regulatory peptides in patients with urticaria pigmentosa. 818 17

The aim of our study was to evaluate the sensitivity of skin mast cells from urticaria pigmentosa (UP) patients to substance P (SP), tumor necrosis factor alpha (TNF-alpha) and anti-IgE, and to compare the sensitivity of these cells with that of skin mast cells from healthy human donors. Mast cells for in vitro functional studies were obtained using an enzymatic dispersion technique from skin biopsies (from 11 patients with UP and 11 healthy donors), and the reactivity of these cells was estimated on the basis of histamine release. Our observations indicated that UP skin mast cells and healthy skin mast cells had similar sensitivities to challenge with TNF-alpha at a concentration 10(-7) M (16.4% vs 15.2%) and with anti-IgE at a dilution 1:100 (41.0% vs 37.0%). However, UP mast cells showed considerably higher sensitivity to challenge with SP at a concentration 10(-4) M than healthy skin mast cells (20.0% vs 6.8%), and the difference was statistically significant (P < 0.001). UP skin mast cells also demonstrated significantly higher spontaneous histamine release than healthy skin mast cells (32.1% vs 12.4%, P < 0.001). Our findings indicating UP skin mast cell sensitivity to SP might suggest that mechanisms involving neurogenic inflammation could contribute to the course of this disease.
 ...
PMID:In vitro reactivity of mast cells in urticaria pigmentosa skin. 952 96